Royal Free's annual return shows 2,102,310 units of cryoprecipitate, 601,681 units of commercial concentrates and 510,200 units of NHS Factor 8. Read more about Royal Free's annual return shows 2,102,310 units of cryoprecipitate, 601,681 units of commercial concentrates and 510,200 units of NHS Factor 8.
Royal Free's annual return recorded that Haemophilia A patients were treated primarily with cryoprecipitate, followed by commercial concentrates, then NHS Factor 8. Read more about Royal Free's annual return recorded that Haemophilia A patients were treated primarily with cryoprecipitate, followed by commercial concentrates, then NHS Factor 8.
Royal Free Hospital began to use commercial concentrate. Read more about Royal Free Hospital began to use commercial concentrate.
Professor Edward Tuddenham was co-director of the Royal Free Hospital. Read more about Professor Edward Tuddenham was co-director of the Royal Free Hospital.
St Thomas' Hospital's annual return for 1978 shows recorded that over a million units of commercial Factor 8 were used that year. Read more about St Thomas' Hospital's annual return for 1978 shows recorded that over a million units of commercial Factor 8 were used that year.
St Thomas' Hospital's annual return for 1978 recorded higher commercial concentrate use than NHS Factor 8. Read more about St Thomas' Hospital's annual return for 1978 recorded higher commercial concentrate use than NHS Factor 8.
St Thomas' Hospital's annual return for 1977 recorded that cryoprecipitate and NHS Factor 8 were the most used products. Read more about St Thomas' Hospital's annual return for 1977 recorded that cryoprecipitate and NHS Factor 8 were the most used products.
St Thomas' Hospital's annual return for 1976 showed that cryoprecipitate and NHS Factor 8 were the most used products. Read more about St Thomas' Hospital's annual return for 1976 showed that cryoprecipitate and NHS Factor 8 were the most used products.
Professor Savidge stated "extra money when found was spent on the purchase of commercial imported factor VIII concentrate, usually from the US, in preference to the safer cryoprecipitate that was the recommend [sic] treatment of children and mild haemophilia patients (assuming failure with DDAVP) generally available (in some regions in excess). Read more about Professor Savidge stated "extra money when found was spent on the purchase of commercial imported factor VIII concentrate, usually from the US, in preference to the safer cryoprecipitate that was the recommend [sic] treatment of children and mild haemophilia patients (assuming failure with DDAVP) generally available (in some regions in excess).
Professor Savidge described UKHCDO in the 1970s and 1980s as an isolated and autonomous advisory body without formal affiliation with the NHS, any Royal College or learned society (eg: British Society on Haematology) with its own self appointed working parties. Read more about Professor Savidge described UKHCDO in the 1970s and 1980s as an isolated and autonomous advisory body without formal affiliation with the NHS, any Royal College or learned society (eg: British Society on Haematology) with its own self appointed working parties.